48 results
Page 2 of 3
8-K
EX-99.1
i0b uiy1cq
31 Jul 20
AbbVie Reports Second-Quarter 2020 Financial Results
8:41am
S-8
EX-4.3
2g4dgsocyg1j7vtioed
19 Jun 20
Registration of securities for employees
5:01pm
8-K
EX-4.15
ir21wyc
14 May 20
AbbVie Announces Final Results of Exchange Offers for Allergan Notes
4:16pm
8-K
EX-4.2
pwxp7denykz c6ctjus
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
424B5
8ntebtg59j 3fd
19 Sep 19
Prospectus supplement for primary offering
5:18pm
424B3
gbjqqsz8a04we
16 Sep 19
Prospectus supplement
6:14am
8-K
EX-10.1
m94g3a0jep4g1vhzd
30 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.2
7qwb98an
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-2.3
gljctjn rkql
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
425
EX-2.1
fbxy3q8
6 Mar 15
Business combination disclosure
12:00am
425
EX-4.1
82rknytf
6 Mar 15
Business combination disclosure
12:00am
8-K
EX-4.1
zpznim5m
6 Mar 15
Entry into a Material Definitive Agreement
12:00am